A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer.

Autor: Novikov SN; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St Petersburg, Russia., Novikov RV; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St Petersburg, Russia., Merezhko YO; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St Petersburg, Russia., Gotovchikova MY; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St Petersburg, Russia., Ilin ND; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St Petersburg, Russia., Melnik YS; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St Petersburg, Russia., Kanaev SV; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St Petersburg, Russia.

Publikováno v: Radiation oncology journal [Radiat Oncol J] 2022 Sep; Vol. 40 (3), pp. 200-207. Date of Electronic Publication: 2022 Sep 30.

[High-dose brachytherapy for prostate cancer in real time using 192-IR (specifics of dosimetric planning)].

Autor: Novikov SN, Kanaev SV, Novikov RV, Iliin ND, Gotovchikova MY

Publikováno v: Voprosy onkologii [Vopr Onkol] 2015; Vol. 61 (1), pp. 130-6.